GE Healthcare, Lilly Pharmacogenomic Alliance Provides Glimpse of GE’s Diagnostics Plans | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Last week’s announcement that GE Healthcare would collaborate with Eli Lilly on a three-year project to develop in vitro diagnostics to predict the response of patients to targeted cancer therapies provides a glimpse of GE’s strategy for the diagnostics market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.